483
Lana M. Rifkin, M.D.FDA 483 - Lana M. Rifkin, M.D. - March 12, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lana M. Rifkin, M.D., a clinical investigator in Boston, MA, revealed a significant deviation from an investigational plan. The firm failed to conduct an investigation in accordance with its protocol, specifically by randomizing and completing the study with subjects who did not meet required inclusion/exclusion criteria. This indicates issues with adherence to study protocols and subject eligibility.
- Person
Open in Dashboard
ID · cbee82a8-3e8f-4ed5-9eca-040e92e9655e